Payer Reps Stress Need to Revise Coverage of Drugs for Minor Illnesses; Kymriah’s Price Isn’t Necessarily too High

Kenporen Director Shoji Kono (right) and Kyokai Kenpo Director Toshikazu Yoshimori Insurer representatives on May 15 called for discussions on revising the scope of coverage for drugs by health insurance programs, focused mainly on drugs for minor illnesses rather than...read more